Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Heads or Tails—What Makes an Amyloid Fibril?

5 September 2002. For some years now scientists have been trying to elucidate the physics behind amyloid fibrils, the multimeric and insoluble strands that cause a variety of amyloidoses, including the plaques of Alzheimer’s disease (see related news item). Today in Nature Structural Biology, researchers in Todd Yeates’ lab at the University of California, Los Angeles, report that the fibrils may be formed by a sucessive head-to-head and tail-to-tail arrangement of individual subunits.

This lab had previously shown that in fibrils of transthyretin, a protein studied as a model for amyloid formation, monomers can bind each other through their respective F β-strands, one of eight present in the molecule (the β-strands are labeled with consecutive letters of the alphabet). But this head-to-head arrangement would limit to just two the number of monomers that can be strung together. Clearly, some other forces must be at work to facilitate fibril growth.

First author Ahmed Serag et al. used site-directed spin labeling, which measures the distance between amino acids, to probe fibrils of transthyretin for likely spots where the monomers may be binding to each other. They found that amino acids on the B β-strands of individual subunits draw near as fibrils form—the gap between two cysteine31s, for example, shortens to 8 Angstroms—indicating that two subunits can bind via their B strands. As the B and F strands are at opposite ends of the molecule it suggests that fibrils form when subunits alternately stack head-to-head and tail-to-tail.

But why does transthyretin only form amyloid fibrils in certain individuals? The authors suggest that for a stable fibril to form, the B β-strands, normally protected from each other by the C and D β-strands, must be exposed. This could happen if the C or D strands are mutated or exposed to an acidic environment, scenarios that have been shown to be fulfilled in vivo.

Serag et al’s model for fibril formation is consistent with work from Jane and David Richardson’s lab at Duke University, Durham, North Carolina, which suggests several mechanisms that have evolved over time to protect proteins with extensive β-strand structure from aggregating to each other. In many cases a single charged amino acid in the middle of an exposed β-strand would suffice.—Tom Fagan.

References:
Serag AA, Altenbach C, Gingery M, Hubbell WL, Yeates TO. Arrangement of subunits and ordering of b-strands in an amyloid sheet. Nat Struct Biol. 2002 Oct ;9(10):734-9. Abstract

Richardson J, Richardson DC. Natural b-sheet proteins use negative design to avoid edge-to-edge aggregation. PNAS 2002 September 5;99:2754-2759. Abstract

 
Comments on News and Primary Papers
  Comment by:  David Teplow
Submitted 9 September 2002  |  Permalink Posted 9 September 2002

Serag et al. report the results of site-directed spin labeling (SDSL) studies of inter-residue distances in native and amyloid-associated forms of transthyretin (TTR). TTR is associated with a number of amyloidoses, including senile systemic amyloidosis and familial amyloid polyneuropathy. The findings are of interest both for understanding the formation of amyloid fibrils by TTR and for understanding basic features of protein folding and design. An important question in this latter area is why proteins with high native b-sheet content do not assemble into amyloid. A systematic investigation into this question (Richardson&Richardson, 2002) revealed that protein evolution has resulted in the inclusion of structural elements in natively folded proteins that "protect" edge β-strands from interactions with neighboring strands that might lead to adventitious and pathologic β-sheet formation. Typically, this type of protection is provided in cis by amino acid sequence elements in the edge strand that inhibit or preclude...  Read more
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad